Sadahisa Ogasawara

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma”.

Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

Liver Cancer(2021)10.1159/000515552

N/A

0.557DataRank · unranked

40 citations

Naoya Kanogawa, Susumu Maruta, Sadahisa Ogasawara, Yotaro Iino, Masamichi Obu +35 more

Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma

Hepatology International(2013)10.1007/s12072-013-9425-4

N/A

0.312DataRank · unranked

7 citations

Fumihiko Kanai, Yoshihiko Ooka, Tenyu Motoyama, Eiichiro Suzuki, Akinobu Tawada +3 more

PS-142-Analysis of sorafenib-regorafenib sequential therapy in patients with advanced hepatocellular carcinoma using baseline date of sorafenib

Journal of Hepatology(2019)10.1016/s0618-8278(19)30160-4

N/A

0.269DataRank · unranked

5 citations

Sadahisa Ogasawara, Yoshihiko Ooka, Kazufumi Kobayashi, Susumu Maruta, Hiroaki Kanzaki +16 more